Noguchi M, Earashi M, Minami M, Kinoshita K, Miyazaki I
Operation Center, Kanazawa University Hospital, School of Medicine, Kanazawa University, Japan.
Oncology. 1995 Nov-Dec;52(6):458-64. doi: 10.1159/000227511.
We investigated the in vitro effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), with or without the addition of linoleic acid (LA), on cell growth and prostaglandin E (PGE) and leukotriene B (LTB) secretion by a human breast cancer cell line (MDA-MB-231). With or without the addition of LA, EPA and DHA suppressed cell growth and thymidine incorporation and reduced the secretion of PGE and LTB. In a univariate analysis, cell growth was significantly associated with both LTB and PGE concentrations when cells were treated with DHA or EPA, independent of the addition of LA. However, multivariate regression analysis showed that cell growth was more closely associated with the PGE concentration rather than the LTB concentration. These data suggest that both EPA and DHA suppress cell proliferation in the MDA-MB-231 cell line by inhibition of the cyclooxygenase rather than the lipoxygenase pathways. However, the exact mechanism underlying the antitumor activity of EPA and DHA remains unclear.
我们研究了二十碳五烯酸(EPA)和二十二碳六烯酸(DHA)在添加或不添加亚油酸(LA)的情况下,对人乳腺癌细胞系(MDA-MB-231)的细胞生长以及前列腺素E(PGE)和白三烯B(LTB)分泌的体外影响。无论是否添加LA,EPA和DHA均能抑制细胞生长和胸苷掺入,并减少PGE和LTB的分泌。在单因素分析中,当细胞用DHA或EPA处理时,细胞生长与LTB和PGE浓度均显著相关,与LA的添加无关。然而,多因素回归分析表明,细胞生长与PGE浓度的相关性比与LTB浓度的相关性更密切。这些数据表明,EPA和DHA均通过抑制环氧化酶而非脂氧化酶途径来抑制MDA-MB-231细胞系中的细胞增殖。然而,EPA和DHA抗肿瘤活性的确切机制仍不清楚。